You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】 資金追南中A50牛或等A股復市 舜宇挑戰100及250天線 恆指牛50714 熊57225/ 全場最貼南中A50牛58464/ 舜光牛53709 熊63754
阿思達克 10-07 11:58
美國總統特朗普叫停與民主黨繼續磋商刺激經濟方案,直至總統大選後才恢復商討。消息拖累美股隔晚倒跌,道指收報27772點,跌375點(或1.3%)。恆指連續兩日高位重上兩萬四,昨收報23980點,升212點(或0.9%),連升三個交易日。今早再升過百點,升穿24,100點。恆指好倉(牛證及認購權證)昨淨流出近8800萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾1億元,反映投資者認為港股升勢將告終。昨日恆指牛證街貨重貨區為收回價22500至22599點,而熊證街貨重貨區為收回價24300至24399點。

A股周五復市,今早即市有資金追入南方A50的牛證。

美團(03690)假期期間外賣訂單急增,10月1日至3日跑腿日均訂單量按年增長151%,其中跑腿代排隊訂單按年大增419%,帶動股份昨最多升逾5%,高見258.4元,收市企258元。美團今早高開逾1%,升幅擴大至逾2%,高見264.6元。昨分別有約320萬元和近810萬元淨流入其好倉和淡倉。

北京國際車展反應熱烈,加上九月內地新能源車熱銷,投資者憧憬中國汽車市場復甦,刺激正積極安排在科創板上市的吉利汽車(00175)昨曾飆6.6%,高見15.7元,收市仍維持逾6%的升幅,報15.62元,是表現最佳藍籌,並收復了周一失地。吉利今早回落逾1%,下試10天線(15.35元)見支持。昨有逾170萬元淨流出其好倉,淡倉同日則有逾20萬元淨流入。

蘋果宣佈下周二舉行發佈會,市場預期iPhone 12將登場,並有機會針對中國市場推出入門版。消息刺激手機設備股上日呈強,舜宇光學(02382)曾升至120元,收升3.4%於119.5元,10天和20天線得而復失。今早反覆向上,高位升穿124元,技術上正在挑戰100及250天線(現同於約124.5元的水平)。昨分別有逾210萬元和逾30萬元淨流出其好倉和淡倉。

中國人壽(02628)昨逆市下跌0.8%,收市險守18元,並結束四日升勢。今早曾再跌逾1%,回至17.8元以下,其後跌幅收窄。昨有逾90萬元淨流入其好倉,淡倉同日則有逾20萬元淨流出。

瑞通相關認股證之選擇:

美團價外、中短期購25361,行使價:326.88元,2021年3月到期,實際槓桿:4.8倍

美團輕微價外、中短期沽25355,行使價:236元,2021年2月到期,實際槓桿:3.6倍

吉利輕微價外、短期購27739,行使價:16.52元,2021年1月到期,實際槓桿:5.4倍

吉利輕微價外、短期沽24680,行使價:14.16元,2021年1月到期,實際槓桿:4.6倍

舜光輕微價外、中短期購25522,行使價:133.8元,2021年2月到期,實際槓桿:4.7倍

舜光輕微價外、短期沽14721,行使價:109.78元,2020年12月到期,實際槓桿:6.4倍

國壽輕微價外、中短期購24200,行使價:19.88元,2021年1月到期,實際槓桿:8.5倍

國壽輕微價外、中短期沽24199,行使價:15.88元,2021年1月到期,實際槓桿:7.1倍

阿里輕微價外、中短期購28625,行使價:305.08元,2021年2月到期,實際槓桿:5.5倍

阿里輕微價外、中短期購19135,行使價:330.18元,2021年1月到期,實際槓桿:7.7倍

瑞通相關牛熊證之選擇:

恆指牛證50714,收回價:23549點,槓桿比率:34倍

恆指熊證57225,收回價:24640點,槓桿比率:35.5倍

美團牛證67680,收回價:230.25元,槓桿比率:6.9倍

美團熊證63796,收回價:284.8元,槓桿比率:9.7倍

舜光牛證53709,收回價:108.99元,槓桿比率:6.1倍

舜光熊證63754,收回價:136.8元,槓桿比率:6.7倍

吉利牛證54633,收回價:14.159元,槓桿比率:7.9倍

吉利熊證64229,收回價:17.89元,槓桿比率:5.2倍

國壽牛證54545,收回價:16.28元,槓桿比率:7.5倍

國壽熊證51256,收回價:19.1元,槓桿比率:9.2倍

全場最貼南中A50牛證58464,收回價:15.98元,槓桿比率:16.8倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account